Omalizumab for Urticarial Vasculitis: Case Report and Review of the Literature

Table 1

Patients with urticarial vasculitis treated with omalizumab.

Author	Year	Case	Dose of omalizumab	Effect of omalizumab
Del Pozo et al. [3]	2012	Female, aged 51, with SLE and urticarial vasculitis. No improvement with oral corticosteroids, antihistamines, and azathioprine	Unknown: based on weight and IgE	Significant improvement Lesions disappeared. No hives or pain
Varricchi et al. [7]	2012	Female, aged 44, with asthma, Churg-Strauss syndrome, and urticarial vasculitis. No improvement with oral corticosteroids, antihistamines, azathioprine, and cyclosporine	300 mg s.c. every two weeks	Significant improvement of symptoms
Díez et al. [8]	2013	Three females with chronic spontaneous urticaria with autoimmune and pressure components plus vasculitis. No improvement with antihistamines, leukotriene receptor antagonists, and cyclosporine	150 mg s.c. every four weeks (two patients) and 300 mg s.c. every four weeks (one patient)	Remission of symptoms in all three patients
Sussman et al. [9]	2014	One patient, unknown gender and age, with urticarial vasculitis	150 mg s.c. every four weeks	Remission of symptoms. Details not given